Literature DB >> 21488483

Alexithymia and chronic diseases: the state of the art.

Ilaria Baiardini1, Silvia Abbà, Margherita Ballauri, Giulia Vuillermoz, Fulvio Braido.   

Abstract

BACKGROUND: Alexithymia is a disorder of the regulatory mechanism of the emotion elaboration; it is characterized by difficulties in differentiating and describing feelings. Research indicates that alexithymia can be considered as a possible risk factor for a variety of medical conditions as it may increase susceptibility to disease development. The interest in alexithymia has increased considerably over the past decade. The present review was aimed at providing a state of the art of recent research on alexithymia in patients with chronic diseases.
METHODS: We reviewed most relevant papers on alexithymia and its relationships with chronic diseases.
RESULTS: Numerous investigations have been conducted in the fields of clinical research, cognitive psychology, neurobiology, and psycho-neuro endocrinology. Some researchers link alexithymia with insecure parental attachment and adverse childhood experiences. Alexithymia seems to be associated with different pathologies and it seems to be an element of co-morbidity associated with an increased risk of mortality. Moreover has been underlined the role of alexithymia in influencing illness behaviours and as a consequence it influences clinical and patients reported outcomes.
CONCLUSION: Several processes or mechanisms by which alexithymia may influence health and illness have been explored. Present research findings on alexithymia suggest important implications for the management of chronic diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21488483

Source DB:  PubMed          Journal:  G Ital Med Lav Ergon        ISSN: 1592-7830


  6 in total

1.  [Etiopathogenetic aspects of somatoform disorders].

Authors:  M Noll-Hussong; H Gündel
Journal:  Nervenarzt       Date:  2012-09       Impact factor: 1.214

2.  Women's quality of sleep and in vitro fertilization success.

Authors:  Marco Reschini; Massimiliano Buoli; Federica Facchin; Alessia Limena; Chiara Dallagiovanna; Valentina Bollati; Edgardo Somigliana
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

Review 3.  Psychosocial Mediators of Change and Patient Selection Factors in Oral Immunotherapy Trials.

Authors:  Audrey Dunn Galvin; J O'B Hourihane
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

4.  Alexithymia and fibromyalgia: clinical evidence.

Authors:  Marialaura Di Tella; Lorys Castelli
Journal:  Front Psychol       Date:  2013-12-02

5.  Influence of alexithymia on the management of Latin American patients with asthma: A cross-sectional study.

Authors:  Emanuel Vanegas; Miguel Felix; German D Ramon; Orlando López Jove; Edgar Emilio Matos Benavides; Iván Tinoco-Morán; Jonathan A Bernstein; Iván Cherrez-Ojeda
Journal:  SAGE Open Med       Date:  2020-06-07

6.  Alexithymia in Patients with Psoriasis: A Cross-Sectional Study from Ecuador.

Authors:  Ivan Cherrez-Ojeda; Emanuel Vanegas; Miguel Felix; Sofia Cherrez; Delia Suárez-Almendariz; Johana Ponton; Vladimir Preciado; Edgar Ollague-Cordova; Enrique Loayza
Journal:  Psychol Res Behav Manag       Date:  2019-12-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.